A detailed history of Lindbrook Capital, LLC transactions in Grifols Sa stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,912 shares of GRFS stock, worth $15,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,912
Previous 1,593 20.03%
Holding current value
$15,678
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$6.27 - $7.7 $2,000 - $2,456
319 Added 20.03%
1,912 $12,000
Q1 2024

Apr 25, 2024

SELL
$5.47 - $11.38 $1,208 - $2,514
-221 Reduced 12.18%
1,593 $10,000
Q4 2023

Jan 31, 2024

BUY
$7.71 - $11.56 $6,653 - $9,976
863 Added 90.75%
1,814 $20,000
Q3 2023

Oct 25, 2023

BUY
$8.91 - $10.91 $187 - $229
21 Added 2.26%
951 $8,000
Q2 2023

Jul 28, 2023

SELL
$7.14 - $9.29 $1,349 - $1,755
-189 Reduced 16.89%
930 $8,000
Q1 2023

Apr 26, 2023

SELL
$6.65 - $10.69 $4,901 - $7,878
-737 Reduced 39.71%
1,119 $8,000
Q4 2022

Jan 24, 2023

SELL
$5.96 - $8.53 $6,818 - $9,758
-1,144 Reduced 38.13%
1,856 $0
Q3 2022

Nov 10, 2022

SELL
$5.95 - $14.3 $14,190 - $34,105
-2,385 Reduced 44.29%
3,000 $18,000
Q2 2022

Aug 01, 2022

BUY
$10.6 - $13.28 $2,618 - $3,280
247 Added 4.81%
5,385 $64,000
Q1 2022

Apr 21, 2022

SELL
$10.37 - $12.73 $7,756 - $9,522
-748 Reduced 12.71%
5,138 $60,000
Q4 2021

Jan 18, 2022

BUY
$10.21 - $15.27 $52,162 - $78,014
5,109 Added 657.53%
5,886 $66,000
Q3 2021

Nov 05, 2021

BUY
$14.07 - $17.3 $1,294 - $1,591
92 Added 13.43%
777 $11,000
Q1 2021

Apr 28, 2021

SELL
$15.15 - $19.78 $1,848 - $2,413
-122 Reduced 15.12%
685 $12,000
Q4 2020

Jan 27, 2021

SELL
$16.86 - $19.67 $961 - $1,121
-57 Reduced 6.6%
807 $15,000
Q3 2020

Nov 03, 2020

BUY
$15.4 - $20.16 $3,696 - $4,838
240 Added 38.46%
864 $15,000
Q2 2020

Jul 27, 2020

BUY
$18.24 - $21.45 $1,568 - $1,844
86 Added 15.99%
624 $11,000
Q1 2020

Apr 22, 2020

SELL
$16.28 - $25.63 $13,447 - $21,170
-826 Reduced 60.56%
538 $11,000
Q3 2019

Oct 31, 2019

BUY
$19.85 - $22.76 $8,098 - $9,286
408 Added 42.68%
1,364 $27,000
Q2 2019

Jul 24, 2019

BUY
$17.59 - $21.1 $3,394 - $4,072
193 Added 25.29%
956 $20,000
Q1 2019

Apr 23, 2019

SELL
$18.01 - $20.11 $3,223 - $3,599
-179 Reduced 19.0%
763 $15,000
Q4 2018

Feb 07, 2019

BUY
$17.44 - $21.53 $16,428 - $20,281
942 New
942 $17,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.